{"name":"Hongqian Guo","slug":"hongqian-guo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBpWmRhbTZOanlwUk9xa2RyMUg1SnQzU1VRSFlZMktOVWpoNm45RWpncG9KbzVrX0FVVUdKRFY0anljZW9xcFR6MUlZWEZDc0Y0NERPQWJzc3VoX1NVbXFj?oc=5","date":"2026-02-07","type":"pipeline","source":"Nature","summary":"Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND - Nature","headline":"Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HT3lvQTdvMF9JaXFuSzlpaWtLOTJoN0tHWFh0OTJXZ3EwdXd6d293dHlLY0t5dE16dkpSaTNtVWNqSEZJQkxfNGtTVXlpN3NVZ1VsQjdKZ1VvQ0FLV0tB?oc=5","date":"2024-09-12","type":"trial","source":"Nature","summary":"First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors - Nature","headline":"First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9qR2pWUUhnbzFWZzFydHlOcnlxWXJXR1BFRDlxeGlIaGNmV0RTWGhQUFNIUnZ0NVhWazJudE9BTl9iS2tTYzB1MWZaeTY1aVNiWFI1dVRUUU9UdlJnZjFxbFZGckZXZUtDcnRJ?oc=5","date":"2022-05-25","type":"pipeline","source":"Wiley Online Library","summary":"Crosstalk between IL‐15Rα+ tumor‐associated macrophages and breast cancer cells reduces CD8+ T cell recruitment - Wiley Online Library","headline":"Crosstalk between IL‐15Rα+ tumor‐associated macrophages and breast cancer cells reduces CD8+ T cell recruitment","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}